Mapping the Path to Sustainable Rare Disease Access in APAC

Situation A global biopharmaceutical company specializing in rare diseases was exploring expansion into select Asia-Pacific (APAC) markets and needed to determine whether its products could be made accessible to patients in markets with limited public reimbursement and private insurance coverage. The company needed a clear view of patient affordability, available funding mechanisms, and the broader … Continued

Asian Hospital and Healthcare Management: Axios CEO Discusses Vision for the Future of Access in Asia

Dr. Joseph Saba discussed Axios International’s vision for the future of access, reflecting on the company’s origins and the evolution of tools such as PFET, PNAT and Axios+ to address different barriers throughout the patient journey. Patients can encounter multiple barriers to treatment, including affordability, individual needs, adherence and challenges navigating healthcare systems. The evolution … Continued